Literature DB >> 23054859

Incomplete Kawasaki disease followed by systemic onset juvenile idiopathic arthritis- the diagnostic dilemma.

Shivani Dogra1, Arushi Gehlot, Deepti Suri, Amit Rawat, Rohit Manoj Kumar, Surjit Singh.   

Abstract

The authors report an 18-mo-old girl who presented with features of incomplete Kawasaki disease and was refractory to intravenous immunoglobulin and infliximab treatment. She subsequently responded to pulse intravenous methylprednisolone therapy. The diagnostic dilemma arose after 2 mo when she developed clinical features suggestive of systemic onset juvenile idiopathic arthritis. Since both diseases have overlapping clinical features and no specific diagnostic laboratory tests, it is difficult for the clinicians even in the best of centers to reach a definitive diagnosis as illustrated by the index case.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23054859     DOI: 10.1007/s12098-012-0893-7

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN: 0019-5456            Impact factor:   1.967


  9 in total

1.  Failure to distinguish systemic-onset juvenile idiopathic arthritis from incomplete Kawasaki disease in an infant.

Authors:  Haruki Komatsu; Akihiko Tateno
Journal:  J Paediatr Child Health       Date:  2007-10       Impact factor: 1.954

2.  Incomplete Kawasaki syndrome followed by systemic onset-juvenile idiopathic arthritis mimicking Kawasaki syndrome.

Authors:  Donato Rigante; Piero Valentini; Roberta Onesimo; Donatella Francesca Angelone; Alessia De Nisco; Giulia Bersani; Angelica Bibiana Delogu
Journal:  Rheumatol Int       Date:  2009-05-20       Impact factor: 2.631

3.  Kawasaki disease: more patients are being diagnosed who do not meet American Heart Association criteria.

Authors:  M T Witt; L L Minich; J F Bohnsack; P C Young
Journal:  Pediatrics       Date:  1999-07       Impact factor: 7.124

4.  Coronary artery dilation among patients presenting with systemic-onset juvenile idiopathic arthritis.

Authors:  Bryce A Binstadt; Jami C Levine; Peter A Nigrovic; Kimberlee Gauvreau; Fatma Dedeoglu; Robert C Fuhlbrigge; Steven N Weindling; Jane W Newburger; Robert P Sundel
Journal:  Pediatrics       Date:  2005-06-01       Impact factor: 7.124

Review 5.  Systemic onset juvenile idiopathic arthritis with macrophage activation syndrome misdiagnosed as Kawasaki disease: case report and literature review.

Authors:  Sharath Kumar; Balu Vaidyanathan; S Gayathri; L Rajam
Journal:  Rheumatol Int       Date:  2010-12-05       Impact factor: 2.631

6.  Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association.

Authors:  Jane W Newburger; Masato Takahashi; Michael A Gerber; Michael H Gewitz; Lloyd Y Tani; Jane C Burns; Stanford T Shulman; Ann F Bolger; Patricia Ferrieri; Robert S Baltimore; Walter R Wilson; Larry M Baddour; Matthew E Levison; Thomas J Pallasch; Donald A Falace; Kathryn A Taubert
Journal:  Circulation       Date:  2004-10-26       Impact factor: 29.690

7.  Corticosteroid treatment of refractory Kawasaki disease.

Authors:  Bianca A Lang; Rae S M Yeung; Kiem G Oen; Peter N Malleson; Adam M Huber; Mark Riley; Regan Ebbeson; Suzanne E Ramsey; Ronald M Laxer; Earl D Silverman; Brian W McCrindle; Savithiri Ratnapalan; Brian M Feldman
Journal:  J Rheumatol       Date:  2006-04       Impact factor: 4.666

Review 8.  Pulse methylprednisolone therapy in the treatment of immune globulin-resistant Kawasaki disease: case report and review of the literature.

Authors:  Jeng-Juh Hung; Cheng-Hsun Chiu
Journal:  Ann Trop Paediatr       Date:  2004-03

9.  Incomplete, atypical kawasaki disease or evolving systemic juvenile idiopathic arthritis: a case report.

Authors:  Shakeel Shaikh; Sidra Ishaque; Taimur Saleem
Journal:  Cases J       Date:  2009-08-06
  9 in total
  5 in total

Review 1.  2021 Update on the Clinical Management and Diagnosis of Kawasaki Disease.

Authors:  Frank Zhu; Jocelyn Y Ang
Journal:  Curr Infect Dis Rep       Date:  2021-02-06       Impact factor: 3.725

2.  Serum IL-18 as a potential specific marker for differentiating systemic juvenile idiopathic arthritis from incomplete Kawasaki disease.

Authors:  Tadamori Takahara; Masaki Shimizu; Yasuo Nakagishi; Noriko Kinjo; Akihiro Yachie
Journal:  Rheumatol Int       Date:  2014-06-12       Impact factor: 2.631

3.  Safety netting versus overtreatment in paediatrics: viral infection or incomplete Kawasaki disease?

Authors:  Jennifer Michelle Charlesworth; Bernadette Power; Edina Moylett
Journal:  BMJ Case Rep       Date:  2017-11-08

Review 4.  2021 Update on the Clinical Management and Diagnosis of Kawasaki Disease.

Authors:  Frank Zhu; Jocelyn Y Ang
Journal:  Curr Infect Dis Rep       Date:  2021-02-06       Impact factor: 3.725

Review 5.  The Clinical Diagnosis and Management of Kawasaki Disease: a Review and Update.

Authors:  Frank H Zhu; Jocelyn Y Ang
Journal:  Curr Infect Dis Rep       Date:  2016-09       Impact factor: 3.725

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.